← Back to Search

Behavioral Intervention

Pain Exposure Therapy for Fibromyalgia (BPET Trial)

N/A
Recruiting
Led By John Sturgeon, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Physician diagnosis of fibromyalgia (FM)
Be older than 18 years old
Must not have
Indication of a co-occurring (non-fibromyalgia) cause of chronic pain
Inability to provide informed consent and complete study procedures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1, day 210
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to determine if a short online treatment using Zoom can assist adults with fibromyalgia in learning helpful methods for managing pain, disability, and other associated issues like depression or anxiety.

Who is the study for?
This trial is for adults with fibromyalgia, a condition causing widespread pain and tenderness. Participants should be comfortable using Zoom for therapy sessions aimed at reducing pain and related issues like disability, depression, or anxiety.
What is being tested?
The study tests Brief Pain Exposure Therapy (BPET), a Zoom-based behavioral treatment designed to teach effective strategies for managing the symptoms of fibromyalgia.
What are the potential side effects?
Since BPET is a type of psychological therapy delivered via Zoom, it does not have physical side effects like medications do. However, discussing painful experiences may cause temporary emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with fibromyalgia by a doctor.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have chronic pain not caused by fibromyalgia.
Select...
I am unable to understand or follow the study's procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1, day 210
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1, day 210 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in pain intensity based on the Numeric Pain Rating Scale between day 1 (T1) and day 60 (T5)
Secondary study objectives
Acceptability of intervention based on Mean scores on the Treatment Acceptability and Adherence Scale (TAAS)
Change in PROMIS Pain Interference from day 1 (T1) to day 210 (T8)
Change in TSK from day 1 (T1) to day 210 (T8)
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Brief pain exposure therapy (BPET)Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,855 Previous Clinical Trials
6,435,031 Total Patients Enrolled
John Sturgeon, PhDPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
300 Total Patients Enrolled
~6 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top